Macclesfield, United Kingdom

James Mccabe

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Dizal (Jiangsu) Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Mccabe. Retrieved from https://idiyas.com/inventor/james-mccabe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: James McCabe: Innovator in Pharmaceutical Compounds

Introduction

James McCabe is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating JAK-related disorders.

Latest Patents

James McCabe holds 1 patent for his work on "Compounds and methods for inhibiting JAK." This patent discloses compounds of formula (I), pharmaceutical compositions comprising such compounds, and methods for using them to treat conditions such as cancer, cancer cachexia, or immune disorders.

Career Highlights

Throughout his career, James has worked with prominent companies in the pharmaceutical industry, including Dizal (Jiangsu) Pharmaceutical Co., Ltd. and Dizal Pharmaceutical Co., Limited. His work has focused on innovative solutions that address critical health issues.

Collaborations

James has collaborated with esteemed colleagues, including Dedong Wu and Tudor Grecu, to advance his research and development efforts in the pharmaceutical sector.

Conclusion

James McCabe's contributions to pharmaceutical innovations highlight his commitment to improving health outcomes through targeted therapies. His work continues to influence the field and inspire future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…